Protein Z and protein Z-dependent protease inhbitor. Determinants of level and risk of venous thrombosis

Thrombosis and Haemostasis

Volumn 93, Issue 3, 2005, Pages 411-413

  Al Shanqeeti, Ali ^a   van Hylckama Vlieg, Astrid ^b   Berntorp, Erik ^c   Rosendaal, Frits R ^b   Broze Jr , George J ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Clinical epidemiological studies; Coagulation inhibitors; Thrombophilia

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; FATTY ACID BINDING PROTEIN; MONOCLONAL ANTIBODY; ORAL CONTRACEPTIVE AGENT; PROTEINASE INHIBITOR; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR RISK; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFECT; FEMALE; HUMAN; IMMUNOASSAY; INTERNATIONAL NORMALIZED RATIO; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ORAL CONTRACEPTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SEX DIFFERENCE; THROMBOPHILIA;

ADOLESCENT; ADULT; AGED; BLOOD PROTEINS; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SERPINS; VENOUS THROMBOSIS; WARFARIN;

EID: 15344345528     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-11-0715     Document Type: Article

References (25)

1. Sejima H, Hayashi T, Deyashiki Y, et al. Primary structure of vitamin K-dependent human protein Z. Biochem Biophys Res Common 1990; 171: 661-8.
2. Ichinose A, et al. Amino acid sequence of human protein Z, a vitamin K-dependent plasma glycoprotein. Biochem Biophys Res Common 1990; 172: 1139-44.
3. Han X, Fiehler R, Broze GJ Jr. Isolation of a protein Z-dependent plasma protease inhibitor. Proc Natl Acad Sci USA 1998; 95: 9250-5.
4. Han X, Huang Z-F, Fiehler R, et al. The protein Z-dependent protease inhibitor is a serpin. Biochemistry 1999; 38: 11073-8.
5. Han X, Fiehler R, Broze GJ Jr. Characterization of protein Z-dependent protease inhibitor. Blood 2000; 96: 3049-55.
6. Miletich JP, Broze GJ Jr. Human plasma protein Z antigen: range in normal subjects and the effect of warfarin therapy. Blood 1987; 69: 1580-6.
7. Tabatabai A, Fiehler R, Broze GJ Jr. Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor. Thromb Haemost 2001; 85: 655-60.
8. Yin Z-F, Huang Z-F, Cui J, et al. Prothrombotic phenotype of protein Z deficiency. Proc Natl Acad Sci USA 2000; 97: 6734-8.
9. Vasse M, Guegan-Massardier E, Borg J-Y, et al. High frequency of protein Z deficiency in patients with ischemic stroke. Lancet 2001; 357: 933-4.
10. Kobelt K, Biasiutti FD, Mattle HP et al. Protein Z in ischaemic stroke. Br J Haematol 2001; 114: 169-73.
11. Heeb MJ, et al. Low protein Z levels and risk of ischemic stroke: differences by diabetic status and gender. Blood Cells Mol Dis 2002; 29: 139-44.
12. Lichy C, Kropp S, Dong-Si T, et al. A common polymorphism of the protein Z gene is associated with protein Z plasma levels and with risk of cerebral ischemia in the young. Stroke 2004; 35: 40-5.
13. Lopaciuk S, et al. Protein Z in young survivors of ischemic stroke. Thromb Haemost 2002; 88: 436.
14. McQuillan AM, Eikelboom JW, Hankey GJ, et al. Protein Z in ischemic stroke and its etiologic subtypes. Stroke 2003; 34: 2415-9.
15. Santacroce R, Cappucci F, Di Perna P, et al. Protein Z gene polymorphisms are associated with protein Z plasma levels. J Thromb Haemost 2004; 2: 1197-9.
16. Fedi S, et al. Low protein Z plasma levels are independently associated with acute coronary syndromes. Thromb Haemost 2003; 90: 1173-8.
17. Gris J-C, Quere I, Dechaud H, et al. High frequency of protein Z deficiency in patients with unexplained early fetal loss. Blood 2002; 99: 2606-8.
18. Steffano B, Forastiero R, et al. Low plasma protein Z levels in patients with antiphospholipid antibodies. Blood Coagul Fibrinolysis 2001; 12: 411-2.
19. McColl MD, Deans A, Maclean P, et al. Plasma protein Z deficiency is common in women with antiphospholipid antibodies. Br J Haematol 2003; 120: 907-15.
20. Forastiero RR, Matinuzzo ME, et al. Autoimmune antiphospholipid antibodies impair the inhibition of activated factor X by protein Z/protein Z-dependent protease inhibitor. J Thromb Haemost 2003; 1: 1764-70.
21. Rice GI, Futers TS, Grant PJ. Identification of novel polymorphisms within the protein Z gene, haplotype distribution and linkage analysis. Thromb Haemost 2001; 85: 1123-4.
22. van der Meer FJM, Koster T, Vandenbroucke JP, et al. The Leiden Thrombophilia Study (LETS). Thromb Haemost 1997; 78: 631-5.
23. Jerkeman A, et al. Correlation between different intensities of anti-vitamin K treatment and coagulation parameters. Thromb Res 2000; 98: 467-71.
24. Kemkes-Matthes B, et al. Protein Z influences the prothrombotic phenotype of factor V Leiden in humans. Thromb Res 2002; 106: 183-5.
25. Cui, J, Eitzman DT, Westrick RJ, et al. Spontaneous thrombosis in mice carrying the factor V Leiden mutation. Blood 2000; 96: 4222-6.